Insmed Incorporated
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Insmed Incorporated's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Growth Efficiency Ratio: Sales grew 147% in 3 years, but profit fell: $220 less profit per $100 of extra sales. Lower than 92% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-31.8×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 66% of Healthcare companies in United States.
Cash Locked Ratio
$28For every $100 of sales, $28 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $17 tied up three years earlier.
More money tied up than 60% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 0/3Sales grew in 3 of the last 3 years; profit grew in 0 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
−$220Sales grew 147% in 3 years, but profit fell: $220 less profit per $100 of extra sales.
Lower than 92% of Healthcare companies in United States.
Asset Productivity Ratio
+147% / +37%In 3 years sales changed by +147% while total assets changed by +37%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-73.0×Operating cash was negative last year, while some debt falls due within a year.
Lower than 79% of Healthcare companies in United States.
Cash Cushion Ratio
+4%Cash, after subtracting all debt, equals 4% of its market value (net cash).
Lower than 59% of Healthcare companies in United States.
Tangible Assets Ratio
90%Of every $100 the company owns, $90 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 61% of Healthcare companies in United States.
Tangible Net Worth Ratio
68%Of every $100 of net worth, $68 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 55% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Insmed Incorporated made a loss over the last year. Insmed Incorporated owes $0.64 for every $1 it owns. Insmed Incorporated made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossInsmed Incorporated made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
27.41The share price is 27.41 times Insmed Incorporated's book value per share, higher than 96% of Healthcare companies in United States.
Market cap
$20.8 BThe total market value of all of Insmed Incorporated's shares at today's price (share price × number of shares), larger than 93% of Healthcare companies in United States. PosiCap size class: Tito Cap.
Net worth (book value)
$757 MWhat Insmed Incorporated would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$3.47Net worth divided by the number of shares. The share price of $95.06 is 27.4 times this, which is the P/B above.
Return on equity (ROE)
-87.2%Insmed Incorporated lost 87.2% of its shareholders' money over the last year, lower than 67% of Healthcare companies in United States.
Owes vs Owns
0.64×Insmed Incorporated owes $0.64 for every $1 it owns (moderate), higher than 67% of Healthcare companies in United States.
Dividend yield
NoneInsmed Incorporated does not currently pay a dividend.
Revenue growth
+67%Revenue rose 67% in the year to Dec 2025, and grew 35% a year on average over 3 years.
Profit growth
LossInsmed Incorporated made a loss in each of the last two years.
Profit margin
-210.5%Insmed Incorporated lost $211 for every $100 of revenue.
Interest cover
Not coveredInsmed Incorporated's operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashInsmed Incorporated held $843 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Insmed Incorporated: $20.8 B ÷ $757 M (30 Jun 2026) = 27.4.
What is Insmed Incorporated's return on equity?
Insmed Incorporated lost 87.2% of its shareholders' money over the last year, lower than 67% of Healthcare companies in United States.
How much does Insmed Incorporated owe compared with what it owns?
Insmed Incorporated owes $0.64 for every $1 it owns (moderate), higher than 67% of Healthcare companies in United States.
Does Insmed Incorporated pay a dividend?
No. Insmed Incorporated does not currently pay a dividend.
Is Insmed Incorporated's revenue growing?
Revenue rose 67% in the year to Dec 2025, and grew 35% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.